dalteparin has been researched along with Pregnancy in Diabetes in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kini, U | 1 |
| Hurst, JA | 1 |
| Byren, JC | 1 |
| Wall, SA | 1 |
| Johnson, D | 1 |
| Wilkie, AO | 1 |
| Fatima, S | 1 |
| Watson, J | 1 |
| Douek, I | 1 |
| Fox, R | 1 |
2 other studies available for dalteparin and Pregnancy in Diabetes
| Article | Year |
|---|---|
Etiological heterogeneity and clinical characteristics of metopic synostosis: Evidence from a tertiary craniofacial unit.
Topics: Adolescent; Anticoagulants; Child; Child, Preschool; Chromosome Aberrations; Craniosynostoses; Enoxa | 2010 |
Limitation of proteinuria rise in diabetic pregnancy: possible benefits of enoxaparin.
Topics: Adult; Anticoagulants; Diabetes Mellitus, Type 1; Enoxaparin; Female; Humans; Pregnancy; Pregnancy i | 2010 |